Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b5f41889212134f724ee94357d02f4b |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K20-126 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-899 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-365 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K20-126 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-899 |
filingDate |
2016-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7f50d48768bfc729ce90272aa0dd551 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be339f4105fd136076753e442df33cb1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_099c3d23cd3b75f0ac430e3d617fd6b8 |
publicationDate |
2018-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20180059021-A |
titleOfInvention |
Composition comprising momilactone b for preventing and treating ketosis |
abstract |
The present invention relates to a pharmaceutical composition for preventing and treating ketosis comprising momilactone B. According to the present invention as described above, the mechanism of inhibiting the production of a ketol body of mymilactone B is revealed, so that it can be usefully used for the development of a mimetic B as a therapeutic agent for ketosis. |
priorityDate |
2016-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |